Who owns SEELOS THERAPEUTICS ORD?
- Ticker: SEEL
- CUSIP Number: 81577f208
Tip: Access positions for across all investors
Analyze quarterly positions in Seelos Therapeutics Ord with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Seelos Therapeutics Ord stock
Who bought or sold SEELOS THERAPEUTICS ORD this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Wealth Effects | 467k | $276k | 104% | Mar 2024 |
|
| AdvisorShares Investments | 463k | $274k | 100% | Mar 2024 |
|
| Jeffrey L. Gendell | 429k | $254k | 284% | Mar 2024 |
|
| Balyasny Asset Management | 379k | $224k | 43% | Mar 2024 |
|
| Vanguard Group | 281k | $166k | -1% | Mar 2024 |
|
| Modera Wealth Management | 158k | $93k | 126% | Mar 2024 |
|
| Morgan Stanley | 126k | $75k | 100% | Mar 2024 |
|
| Geode Capital Management | 102k | $61k | 100% | Mar 2024 |
|
| BlackRock | 56k | $33k | 100% | Mar 2024 |
|
| Strategic Family Wealth Counselors | 30k | $42k | 100% | Dec 2023 |
|
| Jane Street | 23k | $14k | 100% | Mar 2024 |
|
| XTX Topco | 16k | $9.5k | 100% | Mar 2024 |
|
| Two Sigma Investments | 13k | $7.7k | -48% | Mar 2024 |
|
| CRA Financial Services | 12k | $7.0k | 100% | Mar 2024 |
|
| Tower Research Capital | 11k | $6.2k | 100% | Mar 2024 |
|
| UBS Group | 10k | $6.0k | 2398% | Mar 2024 |
|
| Wealth Enhancement Advisory Services | 10k | $5.9k | 100% | Mar 2024 |
|
| Advisor Group Holdings | 8.2k | $4.8k | -6% | Mar 2024 |
|
| Carmichael Hill & Associates | 8.0k | $4.7k | 60% | Mar 2024 |
|
| Jpmorgan Chase & Co | 4.0k | $2.4k | 100% | Mar 2024 |
|
| Bank of America Corporation | 3.8k | $2.2k | 0% | Mar 2024 |
|
| Group One Trading | 1.8k | $1.1k | 100% | Mar 2024 |
|
| Crewe Advisors | 925.00 | $1.3k | 100% | Dec 2023 |
|
| Wells Fargo & Company | 440.00 | $259.072000 | 19% | Mar 2024 |
|
| First Manhattan | 372.00 | $218.996400 | 100% | Mar 2024 |
|
| Newbridge Financial Services Group | 199.00 | $118.007000 | 0% | Mar 2024 |
|
| Hollencrest Securities | 86.00 | $50.998000 | 0% | Mar 2024 |
|
| Aspire Private Capital | 50.00 | $30.000000 | 0% | Mar 2024 |
|
| Westside Investment Management | 33.00 | $19.001400 | 0% | Mar 2024 |
|
| National Bank Of Canada /fi/ | 33.00 | $44.998800 | 100% | Dec 2023 |
|
| Parallel Advisors | 28.00 | $16.998800 | 0% | Mar 2024 |
|
| Pnc Financial Services | 12.00 | $8.000400 | 0% | Mar 2024 |
|
| TSFG | 3.00 | $0 | 0% | Mar 2024 |
|
| Bnp Paribas Arbitrage, Snc | 3.00 | $2.000100 | 100% | Mar 2024 |
|
Who sold out of Seelos Therapeutics Ord?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Mirae Asset Global Investments | Dec 2023 | 304k | $422k |
| Citadel Advisors | Dec 2023 | 45k | $63k |
| Lynwood Capital Management | Dec 2023 | 40k | $56k |
| Royal Bank of Canada | Dec 2023 | 106.00 | $0 |
| TD Waterhouse Canada | Dec 2023 | 66.00 | $87.997800 |
| FNY Investment Advisers | Dec 2023 | 66.00 | $0 |